Oticon Real vs Signia Pure C&G IX

The Oticon Real is a premium behind-the-ear prescription hearing aid released in 2023, currently available at $4,798. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.8/5, placing it in the top 8% of all prescription hearing aids tested and ranking #4 out of 36 devices in its category. Speech performance is a standout strength. Speech in quiet scores an excellent 4.5/5 on initial fit—0.72 points above the category average—while speech in noise scores 3.0/5, nearly a full point above the category average of 1.96/5. While the speech-in-noise result is above average for the category, it remains mixed in absolute terms at 2.9/5 after tuning, reflecting the inherent challenge of noisy environments for all hearing aids. Music streaming quality starts strong at 4.2/5 on initial fit, though it drops to a mixed 2.8/5 after tuning—still slightly above the category average. Feedback handling scores a solid 4.0/5, which is strong in absolute terms, though it falls 0.71 points below the category average of 4.71/5. Own-voice comfort is mixed at 2.4/5, slightly below the category average. The Oticon Real competes directly with other premium devices like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5). It offers versatile connectivity with iPhone and Android streaming plus hands-free capabilities, and supports both rechargeable and disposable batteries. This device is best suited for users prioritizing strong out-of-box speech clarity who want a well-rounded premium hearing aid from a trusted manufacturer.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.